Sensitization to apoptosis underlies KrasD12-dependent oncolysis of murine C26 colorectal carcinoma cells by reovirus T3D

Journal of Virology

Volumn 79, Issue 23, 2005, Pages 14981-14985

  Smakman, Niels ^a   Van Den Wollenberg, Diana J M ^b   Rinkes, Inne H M Borel ^a   Hoeben, Rob C ^b   Kranenburg, Onno ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; ONCOLYTIC VIRUS;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL KILLING; COLORECTAL CARCINOMA; FIBROBLAST; GENE; GENE EXPRESSION REGULATION; KRASD12 GENE; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; REOVIRUS; RNA INTERFERENCE; RNA TRANSLATION; SENSITIZATION; TARGET CELL;

3T3 CELLS; ANIMALS; APOPTOSIS; CARCINOMA; COLORECTAL NEOPLASMS; MICE; REOVIRIDAE;

ANIMALIA; MURINAE; REOVIRUS SP.;

EID: 27744453770     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.23.14981-14985.2005     Document Type: Article

References (25)

1. Agbunag, C., and D. Bar-Sagi. 2004. Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells. Cancer Res. 64:5659-5663.
2. Caron, R. W., A. Yacoub, C. Mitchell, X. Zhu, Y. Hong, T. Sasazuki, S. Shirasawa, M. P. Hagan, S. Grant, and P. Dent. 2005. Radiation-stimulated ERK1/2 and JNK1/2 signaling can promote cell cycle progression in human colon cancer cells. Cell Cycle 4:456-464.
3. Clarke, P., S. M. Meintzer, S. Gibson, C. Widmann, T. P. Garrington, G. L. Johnson, and K. L. Tyler. 2000. Reovirus-induced apoptosis is mediated by TRAIL. J. Virol. 74:8135-8139.
4. Clarke, P., and K. L. Tyler. 2003. Reovirus-induced apoptosis: a minireview. Apoptosis 8:141-150.
5. Clem, R. J., and L. K. Miller. 1994. Control of programmed cell death by the baculovirus genes p35 and iap. Mol. Cell. Biol. 14:5212-5222.
6. Clemens, M. J., and A. Elia. 1997. The double-stranded RNA-dependent protein kinase PKR: structure and function. J. Interferon Cytokine Res. 17:503-524.
7. Coffey, M. C., J. E. Strong, P. A. Forsyth, and P. W. Lee. 1998. Reovirus therapy of tumors with activated Ras pathway. Science 282:1332-1334.
8. Connolly, J. L., E. S. Barton, and T. S. Dermody. 2001. Reovirus binding to cell surface sialic acid potentiates virus-induced apoptosis. J. Virol. 75:4029-4039.
9. Cox, A. D., and C. J. Der. 2003. The dark side of Ras: regulation of apoptosis. Oncogene 22:8999-9006.
10. de Haro, C., R. Mendez, and J. Santoyo. 1996. The eIF-2α kinases and the control of protein synthesis. FASEB J. 10:1378-1387.
11. Dever, T. E. 2002. Gene-specific regulation by general translation factors. Cell 108:545-556.
12. Fallaux, F. J., O. Kranenburg, S. J. Cramer, A. Houweling, H. Van Ormondt, R. C. Hoeben, and A. J. Van Der Eb. 1996. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum. Gene Ther. 7:215-222.
13. Hirasawa, K., S. G. Nishikawa, K. L. Norman, T. Alain, A. Kossakowska, and P. W. Lee. 2002. Oncolytic reovirus against ovarian and colon cancer. Cancer Res. 62:1696-1701.
14. Hirasawa, K., S. G. Nishikawa, K. L. Norman, M. C. Coffey, B. G. Thompson, C. S. Yoon, D. M. Waisman, and P. W. Lee. 2003. Systemic reovirus therapy of metastatic cancer in immune-competent mice. Cancer Res. 63: 348-353.
15. Kilani, R. T., Y. Tamimi, E. G. Hanel, K. K. Wong, S. Karmali, P. W. Lee, and R. B. Moore. 2003. Selective reovirus killing of bladder cancer in a co-culture spheroid model. Virus Res. 93:1-12.
16. Lunemann, J. D., S. Waiczies, S. Ehrlich, U. Wendling, B. Seeger, T. Kamradt, and F. Zipp. 2002. Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells. J. Immunol. 168: 4881-4888.
17. Marcato, P., M. Shmulevitz, and P. W. Lee. 2005. Connecting reovirus oncolysis and Ras signaling. Cell Cycle 4:556-559.
18. Nesterov, A., M. Nikrad, T. Johnson, and A. S. Kraft. 2004. Oncogenic Ras sensitizes normal human cells to tumor necrosis factor-alpha-related apoptosis-inducing ligand-induced apoptosis. Cancer Res. 64:3922-3927.
19. Norman, K. L., M. C. Coffey, K. Hirasawa, D. J. Demetrick, S. G. Nishikawa, L. M. DiFrancesco, J. E. Strong, and P. W. Lee. 2002. Reovirus oncolysis of human breast cancer. Hum. Gene Ther. 13:641-652.
20. Norman, K. L., K. Hirasawa, A. D. Yang, M. A. Shields, and P. W. Lee. 2004. Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection. Proc. Natl. Acad. Sci. USA 101:11099-11104.
21. Qi, X., J. Tang, R. Pramanik, R. M. Schultz, S. Shirasawa, T. Sasazuki, J. Han, and G. Chen. 2004. p38 MAPK activation selectively induces cell death in K-ras-mutated human colon cancer cells through regulation of vitamin D receptor. J. Biol. Chem. 279:22138-22144.
22. D12 knockdown on tumorigenesis: increased immune-mediated tumor clearance and abrogation of tumor malignancy. Oncogene, in press.
23. Strong, J. E., M. C. Coffey, D. Tang, P. Sabinin, and P. W. Lee. 1998. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J. 17:3351-3362.
24. Tyler, K. L., M. K. Squier, S. E. Rodgers, B. E. Schneider, S. M. Oberhaus, T. A. Grdina, J. J. Cohen, and T. S. Dermody. 1995. Differences in the capacity of reovirus strains to induce apoptosis are determined by the viral attachment protein sigma 1. J. Virol. 69:6972-6979.
25. Zhang, B., and R. G. Fenton. 2002. Proliferation of IL-6-independent multiple myeloma does not require the activity of extracellular signal-regulated kinases (ERK1/2). J. Cell. Physiol. 193:42-54.